185 related articles for article (PubMed ID: 37563345)
1. Ten-year follow-up of endoscopic mucosal resection versus esophagectomy for esophageal intramucosal adenocarcinoma in the setting of Barrett's esophagus: a Canadian experience.
Fernandes A; Li C; French D; Ellsmere J
Surg Endosc; 2023 Nov; 37(11):8735-8741. PubMed ID: 37563345
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
[TBL] [Abstract][Full Text] [Related]
3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
4. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic mucosal resection for early esophageal carcinoma is effective and safe but necessitates continued surveillance.
Hasan Y; Murali AR; Gerke H
Indian J Gastroenterol; 2020 Oct; 39(5):487-494. PubMed ID: 33201442
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience.
Huntington JT; Walker JP; Meara MP; Hazey JW; Melvin WS; Perry KA
Surg Endosc; 2015 Aug; 29(8):2121-5. PubMed ID: 25472745
[TBL] [Abstract][Full Text] [Related]
8. Trimodal imaging-assisted endoscopic mucosal resection of early Barrett's neoplasia.
Thomas T; Singh R; Ragunath K
Surg Endosc; 2009 Jul; 23(7):1609-13. PubMed ID: 19296171
[TBL] [Abstract][Full Text] [Related]
9. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma: a Canadian experience.
Yamashita DT; Li C; Bethune D; Henteleff H; Ellsmere J
Can J Surg; 2017 Apr; 60(2):129-133. PubMed ID: 28338468
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia.
Podboy A; Kolahi KS; Friedland S; Louie CY
Dig Endosc; 2020 Mar; 32(3):346-354. PubMed ID: 31306525
[TBL] [Abstract][Full Text] [Related]
12. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients.
Schmidt HM; Mohiuddin K; Bodnar AM; El Lakis M; Kaplan S; Irani S; Gan I; Ross A; Low DE
Surg Endosc; 2016 Aug; 30(8):3391-401. PubMed ID: 26541725
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
[TBL] [Abstract][Full Text] [Related]
15. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
16. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
[TBL] [Abstract][Full Text] [Related]
19. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
Luna RA; Gilbert E; Hunter JG
Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
[TBL] [Abstract][Full Text] [Related]
20. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
